Identification of kinases required for glioblastoma stem cell growth and survivalGoel, Surbhi.
Abstract: Glioblastoma multiforme (GBM) is the most common and lethal primary malignant tumor of the central nervous system. The median survival of patients post diagnosis is about 15 months despite the current aggressive standard of care treatment that includes surgical resection followed by radiotherapy and chemotherapy with the DNA alkylating drug temozolomide. Thus, there is an urgent need to ... read more
- Sackler School of Graduate Biomedical Sciences. Department of Genetics.
- Permanent URL
|To Cite:||DCA Citation Guide|